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The method is based on the formation of a yellow ferric citrate complex measured photometrically at 390 nm. There has been some confusion as to the exact procedure to follow. To avoid adding further to that confusion, the procedure that I chose is as follows:
1 (1) took 1.5 mg/mL, which may have caused a slightly larger than 3% dilution. Cholesterol standardization is highly recommended (2-5) in connection with consensus guidelines, and it has become our goal to reduce analytical bias in cholesterol assays (including those performed in screening procedures) to <3% within the next two years. We therefore cannot allow a difference of the same magnitude-between plasma and serum-without correction. A screening method for wholeblood cholesterol should be made comparable to serum cholesterol assays.
My rough estimate is that the bias of -0.8% to 7.8% found in this study of the Reflotron assay would have been -4% to +3% in a serum comparison.
(b) The authors discuss the differLIewls ences they have found in some detail. This is done on the basis of linearregression calculations.
Although the results of linear-regression analysis vs orthogonal regression may be comparable in some data sets, it is certainly not ideal to use the first when the coefficient of correlation (r) is low (<0.97). It is better to carry out an orthogonal or a Passing & Bablok regression (7) in circumstances like those in Table 7 
